Day One Biopharmaceuticals Inc (NASDAQ: DAWN) open the trading on Wednesday, with a bit cautious approach as it glided -9.87% to $6.30, before settling in
On Friday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) opened higher 4.07% from the last session, before settling in for the closing price of $7.62. Price
On Tuesday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) was -0.78% drop from the session before settling in for the closing price of $7.74. A 52-week
On Tuesday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) was 2.66% up from the session before settling in for the closing price of $7.14. A 52-week
Witnessing the stock’s movement on the chart, on Wednesday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) had a quiet start as it plunged -5.98% to $6.76,
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) kicked off on Friday, up 5.33% from the previous trading day, before settling in for the closing price of
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) kicked off on Tuesday, down -4.42% from the previous trading day, before settling in for the closing price of
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) on Tuesday, plunged -4.04% from the previous trading day, before settling in for the closing price of $7.93. Within
As on Thursday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) got off with the flyer as it spiked 0.86% to $8.19, before settling in for the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
